Insights On Outsourced Drug Development

  1. Take The Wheel And Drive Your Oligo Synthesis Where You Want 2/9/2026

    Explore the evolving oligo therapeutic landscape while identifying common challenges of bringing production in‑house and the key factors that shape long‑term success for smoother scale‑up.

  2. Bridging The Gap Between Traditional Models And Human Biology 9/3/2024

    Whether you are new to Organ-on-a-Chip technology or seeking to expand your expertise, watch to gain the knowledge and insights needed to effectively implement this technology into your research.

  3. Keeping The Momentum In Pandemic Preparedness 10/22/2024

    Learn about the partnership between the Prairie HUB and Cytiva to create RNA vaccines to target potential pandemic viruses with the aim of redefining global pandemic preparedness.

  4. NGS In GMP Manufacturing: Reducing Risk, Increasing Return 1/29/2026

    Global regulators now recognize NGS as a rigorous, GMP‑ready tool for viral safety, driving a shift toward scalable quality strategies. Learn why NGS is becoming central to modern manufacturing.

  5. Five Practical Considerations To Move From Concept To Clinic 12/17/2025

    Learn more about five key factors for advancing targeted in vivo LNP programs, from formulation and targeting strategies to bioanalytical readiness and scalability.

  6. Predicting Hepatotoxicity With The Liver-Chip 8/2/2024

    Enhance your understanding of liver organoids and their pivotal role in enhancing DILI risk prediction through the use of advanced Organ-Chip technology.

  7. Column Selection For RPLC-UV Impurity Analysis 7/17/2025

    Explore the performance of four column chemistries for RPLC-UV impurity analysis of liraglutide and semaglutide, which offers practical guidance for method development in peptide-based therapeutics.

  8. Tablet Edge Erosion – Solutions For Friability 11/11/2024

    Addressing tablet edge erosion and friability involves adjusting formulation, tablet design, tooling, press setup, and operation speed to improve tablet robustness and reduce weight loss.

  9. Expanding Translational Research Concepts With Genedata Profiler 11/26/2024

    The biopharma industry leverages Genedata Profiler to integrate, curate, and analyze diverse R&D data, enabling collaborative, compliant, and AI-driven translational research to optimize drug development.

  10. Leveraging Optimized Transient Expression For Material Generation And Early Stage Insight 7/23/2024

    By using an optimized transient transfection platform, drug developers can accelerate their characterization and early development activities, facilitating continuity for a drug's scale-up.